The AMR Centre has combined forces to attract much needed investment to combat the global threat of antimicrobial resistance (AMR) resulting in a successful bid for a £114 million project supported by UK Research and Innovation (UKRI). The funding was secured by a North West UK based consortium that will work in partnership to create an integrated platform for the development of new treatments and diagnostics for infectious diseases.
News
As part of the agreement, Biocair will transport selected blood samples to specialist laboratories for investigation to find out if the individual has developed antibodies against the SARS-CoV-2 virus.
The Bundesliga was the first European football league to restart amidst the ongoing pandemic. As a result, the league has implemented several protective measures to guard staff and players against COVID-19. This includes mandatory testing across all clubs.
Miguel Rodriguez, Client Relationship Manager at Biocair GmbH, comments:
- Start Codon aims to rapidly translate the most disruptive and innovative life science research into successful companies and positive clinical outcomes
- The first cohort of four companies will debut at the Milner Therapeutics Symposium on the 26th June and at OnHelix on the 14th July
June 23, 2020 02:01 AM Eastern Daylight Time
Dr Steven Newhouse is the Head of Technical Services at EMBL's European Bioinformatics Institute (EMBL-EBI). He has previously held roles in the leadership of European Grid Infrastructure activities and was a Program Manager in the High Performance Computing (HPC) group in the Windows server division at Microsoft. Dr Newhouse’s role today involves managing teams that bring both new innovations and established technology services from Europe and around the world to further develop and support the life sciences.
- Experienced tech leader Meri Williams joins Healx - the AI-powered, patient-inspired technology company - from challenger bank Monzo, as Chief Technology Officer.
- In her new role, Meri will focus on scaling Healx’s technology and team following their successful Series B raise of $56 million in October 2019.
- Meri’s appointment consolidates Healx’s focus on technical excellence, and is the latest in several senior appointments at Healx over the last few months.
NORWICH, UK - 17 June 2020: Leaf Expression Systems (Leaf), a contract development and manufacturing organisation based in Norwich, UK, has announced today that it has developed a recombinant SARS-CoV-2 N-protein (antigen) to aid research into the Novel Coronavirus (SARS-CoV-2, 2019-nCoV) pandemic.
Research evidences that well-placed public-sector funding in life sciences drives considerable returns to the UK economy and society
AT247 delivers significantly accelerated absorption of insulin compared to best in class treatments NovoRapid® and Fiasp®
Cambridge, UK., 15 June 2020: Arecor Limited (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives, presented positive results for the Phase I clinical trial of its ultra-rapid acting insulin product candidate, AT247, at the American Diabetes Association 80th Scientific Sessions (ADA) virtual meeting. The abstract, #231-OR, is available on the ADA website.
Pharmaceutical and biotech product development consultancy Boyds has hired regulatory professional Dr Lucie Hwang as associate in its award-winning regulatory affairs team that supports clients facilitating the fast and efficient development of medicinal products.